Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial.

Han SB, Rhim JW, Shin HJ, Lee SY, Kim HH, Kim JH, Lee KY, Ma SH, Park JS, Kim HM, Kim CS, Kim DH, Choi YY, Cha SH, Hong YJ, Kang JH.

Hum Vaccin Immunother. 2015;11(5):1094-102. doi: 10.1080/21645515.2015.1017693.

2.

Immunogenicity of the trivalent inactivated influenza vaccine in young children less than 4 years of age, with a focus on age and baseline antibodies.

Mugitani A, Ito K, Irie S, Eto T, Ishibashi M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Fukuoka Pediatricians Group for Vaccine Efficacy.

Clin Vaccine Immunol. 2014 Sep;21(9):1253-60. doi: 10.1128/CVI.00200-14. Epub 2014 Jul 2.

3.

Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy.

Kang JH.

Korean J Pediatr. 2014 Apr;57(4):164-70. doi: 10.3345/kjp.2014.57.4.164. Epub 2014 Apr 30. Review.

4.

The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012.

Turner N, Pierse N, Bissielo A, Huang QS, Baker MG, Widdowson MA, Kelly H; SHIVERS investigation team.

Vaccine. 2014 Jun 17;32(29):3687-93. doi: 10.1016/j.vaccine.2014.04.013. Epub 2014 Apr 24.

5.

Immunogenicity and safety of an inactivated trivalent split influenza virus vaccine in young children with recurrent wheezing.

Bae EY, Choi UY, Kwon HJ, Jeong DC, Rhim JW, Ma SH, Lee KI, Kang JH.

Clin Vaccine Immunol. 2013 Jun;20(6):811-7. doi: 10.1128/CVI.00008-13. Epub 2013 Mar 27.

6.

Safety and immunogenicity of a new trivalent inactivated split-virus influenza vaccine in healthy Korean children: a randomized, double-blinded, active-controlled, phase III study.

Kang JH, Oh CE, Lee J, Lee SY, Cha SH, Kim DS, Kim HH, Lee JH, Kim JT, Ma SH, Hong YJ, Cheong HJ, Lee HJ.

J Korean Med Sci. 2011 Nov;26(11):1421-7. doi: 10.3346/jkms.2011.26.11.1421. Epub 2011 Oct 27.

7.

Influenza vaccination in young children reduces influenza-associated hospitalizations in older adults, 2002-2006.

Cohen SA, Chui KK, Naumova EN.

J Am Geriatr Soc. 2011 Feb;59(2):327-32. doi: 10.1111/j.1532-5415.2010.03271.x. Epub 2011 Jan 28.

8.

B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant.

Baer J, Santiago F, Yang H, Wu H, Holden-Wiltse J, Treanor J, Topham DJ.

Vaccine. 2010 Jan 22;28(4):907-15. doi: 10.1016/j.vaccine.2009.11.002. Epub 2009 Nov 21.

9.

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children.

Nolan T, Richmond PC, McVernon J, Skeljo MV, Hartel GF, Bennet J, Basser RL.

Influenza Other Respir Viruses. 2009 Nov;3(6):315-25. doi: 10.1111/j.1750-2659.2009.00108.x.

10.

Practical considerations to influenza vaccination.

Musana KA, Yale SH, Mazza JJ, Reed KD.

Clin Med Res. 2004 Nov;2(4):256-9. Review. No abstract available.

11.

Influenza vaccine.

Pai VA, Pai BV.

Arch Dis Child. 2003 Aug;88(8):665. No abstract available.

12.

Routine influenza vaccination for healthy children--old concept, new technologies.

Beyer WE.

Arch Dis Child. 2000 Dec;83(6):461-2. No abstract available.

Supplemental Content

Support Center